A groundbreaking stride in Alzheimer's diagnostics has taken center stage with the U.S. Food and Drug Administration's recent clearance of a non-invasive blood test designed to detect early signs of the disease. Developed by Fujirebio Diagnostics, this test evaluates specific biomarkers
James Maitland, a distinguished expert in the field of robotics and IoT applications within the healthcare industry, joins us today to unravel the complex interplay of technology and policy in shaping the future of healthcare. While his expertise stretches far into the realm of innovation, today’s d
In recent years, the use of audit technologies in Medicare Advantage (MA) plans has taken on growing importance as the program expands to cover a larger share of America's seniors. Audit technologies have become central to ensuring that health plans deliver accurate claims, essential for
James Maitland, a renowned authority on robotics and Internet of Things applications in medicine, brings a wealth of knowledge to the conversation on leveraging technology in healthcare. With a keen insight into current trends, Maitland offers a unique perspective on the intricacies of deploying
In a significant judicial development, the Trump administration's initiative to slash $11 billion in public health funding faced legal obstacles as Rhode Island District Court Judge Mary McElroy issued a preliminary injunction against these cuts. This marks a crucial legal battle where 23
The Food and Drug Administration (FDA) has revised its review process for approving COVID-19 vaccines, adopting more stringent guidelines. This development, expounded in The New England Journal of Medicine by FDA Commissioner Martin Makary and vaccine official Vinay Prasad, critiques previous
